INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "(3-((6-(2-AMINO-BENZO[D]THIAZOL-4-YL)-3-(PYRROLIDIN-1-YL)-7,9-DIHYDROFURO[3,4-F]QUINAZOLIN-1-YL)AMINO)- PIPERIDIN-2-ONE DERIVATIVES AS KRAS INHIBITORS FOR THE TREATMENT OF CANCER"

GENEVA, March 24 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/045670) for "(3-((6-(2-AMINO-BENZO[D]THIAZOL-4-YL)-3-(PYRROLIDIN-1-YL)-7,9-DIHYDROFURO[3,4-F]QUINAZOLIN-1-YL)AMINO)- PIPERIDIN-2-ONE DERIVATIVES AS KRAS INHIBITORS FOR THE TREATMENT OF CANCER" on Sep 10, 2025. With publication no. WO/2026/059955, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARONOW, Sean (c/o Eli Lilly and Company,PO Box 6288Indianapolis, Indiana 46206-6288), BARBERIS, Mar...